Latest News & Features
Patents
The integration of cutting-edge medical technology within the life sciences has ushered in an era of unprecedented innovation, transforming the landscape of healthcare and patient wellbeing. 29 October 2024
Patents
The dynamic landscape of patent law is continually influenced by evolving regulations and legal decisions, and one of the key areas at the forefront of these changes is the Patent Trial and Appeal Board (PTAB). 29 October 2024
Patents
Patents are key to ensuring continued investment in pharma R&D.
What are the unique patent considerations for pharma/biotech patents and AI patents in Europe? 29 October 2024
Patents
Korean pharmaceutical, biotech, and life sciences companies are actively expanding globally, leading to more complex and multifaceted IP strategies than in the past. 29 October 2024
Patents
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field. 29 October 2024
Copyright
A court’s decision in favour of a software company is set to have a ripple effect on cases relating to fair use and artificial intelligence. Marisa Woutersen spoke to the winning counsel to find out more. 29 October 2024
Unified Patent Court
German company files suit against chipmaker at the UPC in Munich | Case marks chipmaker’s first major dispute at the pan-European court | Suit follows Nvidia’s emergence as the world’s most valuable company and Microsoft dispute in the US. 29 October 2024
Patents
Agreement halts all litigation in multiple jurisdictions between the pair | US company agrees to pay royalties to the Finnish telecoms giant for using video technology in its devices. 29 October 2024
Copyright
Member states cannot apply material reciprocity clause in Berne Convention following judgment | Decision relates to dispute over iconic Eames-designed chair 28 October 2024
Patents
A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 for the tech giant | Despite the victory, Masimo says the ruling does not apply to its current products. 28 October 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.